Do you get paid to donate bone marrow?

No, you cannot be paid to donate bone marrow through any US registry. The National Organ Transplant Act of 1984 prohibits compensation for human organs, and bone marrow is classified as an organ under federal law — see 42 U.S.C. § 274e (NOTA), which makes it unlawful to transfer a human organ for valuable consideration. This applies to all donations made through Be The Match / NMDP, DKMS, Gift of Life, and any other US-affiliated registry. The federal donor system itself runs through the HRSA C.W. Bill Young Cell Transplantation Program, which administers the national program under government contract.

Peripheral blood stem cell (PBSC) donation sits in a narrower legal space. In Flynn v. Holder (9th Cir. 2011) (full opinion), the court held that PBSC collected through apheresis is not “bone marrow” under NOTA, because it draws blood-collected stem cells rather than marrow itself. As a practical matter today, no US-affiliated registry pays for PBSC donation. It is a matter of registry policy and the absence of any US compensation market, not a paid program you can join.

What you do get is full coverage of costs. Medical costs, travel, lodging, time off work, and incidental expenses are paid by the receiving patient's insurance or by the registry. You should expect to pay zero out of pocket for a registry-coordinated donation.

The legal reasoning starts with 42 U.S.C. § 274e (NOTA). Congress passed the statute in 1984 out of concern that allowing organ sales would exploit low-income donors, introduce safety risks if donors concealed health history for money, and make organs available mainly to wealthy recipients. The law extended these concerns to bone marrow, treating it as regenerative organ tissue subject to the same prohibition.

There is a medical argument layered on top of the legal one. Registries hold that non-monetary donation produces a more reliable donor pool, because donors motivated by altruism are less likely to back out at the critical moment before a transplant, when a patient's own marrow may already have been cleared in preparation. This claim is debatable, and we present it as the registry industry's position rather than a settled fact.

The PBSC carve-out is the part most pages skip. Even though Flynn v. Holder (9th Cir. 2011) (full opinion) placed apheresis-collected PBSC outside NOTA's definition of a human organ, no major US registry pays for it. Three things explain the gap between what the law allows and what actually happens: registries argue that paid donors would compromise the safety chain, there is no functioning compensation market for unrelated PBSC donation in the US, and registry policy across the board treats donation as a volunteer act. The result is that the theoretical opening Flynn created has never translated into a paid option for ordinary donors.

If your real question is the opposite of getting paid — whether donation will cost you anything — the short answer is no. Here is the itemized version, so there are no surprises.

Compensation policies vary internationally and shift over time, and we will not name a specific country's rule without a current, citable source for it. The practical point is the one that matters to you: US registries do not coordinate with paid donation programs in any country. If you are searching for a paid arrangement, no US-affiliated registry can facilitate it, wherever it might exist.

Online ads offering payment for bone marrow should be treated as fraud or worse. Legitimate US bone marrow donation cannot be paid for, so any “cash for marrow” listing is operating outside the registry system that exists to keep both donors and patients safe. Unaffiliated arrangements raise serious safety and legal concerns, and they bypass the medical screening that protects you as a donor. The only safe route is a registry-coordinated donation.

The reason donation works without payment is that the return is not financial. A single matched donor can give a patient with leukemia, lymphoma, or another blood disorder a chance at a cure that no medication offers. The National Cancer Institute describes how a stem cell transplant rebuilds a patient's blood and immune system from the donor's cells, and the federal outcomes data behind the US program is published by the HRSA C.W. Bill Young Cell Transplantation Program.

Only a minority of registry members are ever called to donate, which is part of why joining costs nothing and asks little of most people who sign up. Being listed means that if you are the rare match for a specific patient, you can be found.

For one account of what that match can mean, read Torsten and Jada's story. Torsten registered after reading a newspaper article in Germany and went on to save the life of a baby five thousand miles away — without payment, and without expecting any. The financial cost to him was zero; the outcome was a life.